Australia, Aug. 25 -- GentiBio Inc., owns the trademark (2525688) for 'GENTIBIO' till Sept. 30, 2034.
Status: protected:
Registered/protected
Class: 5 [Pharmaceutical preparations for use in the treatment of autoimmune diseases and disorders, autoinflammatory diseases and disorders, alloimmune diseases and disorders, allergic diseases and disorders, autoimmune diseases and disorders, acute illness, diabetes, stroke, inflammation and inflammatory disease, respiratory and infectious diseases, acute respiratory distress illness, immunological disorders and metabolic diseases; human cells for medical purposes; cells for medical therapy use; cultured human cells for therapeutic use.]
Type of Mark: Word
Date of Acceptance: June 16
Registration Advertised: Aug. 24
For further details contact Davies Collison Cave Pty. Ltd. and John V. Hobgood, Esquire Wilmer Cutler Pickering Hale and Dorr LLP .
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2525688.
Disclaimer: Curated by HT Syndication.
